Releases
LHDX
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Lucira Health, Inc. (LHDX) stock and general news. This information may help you make smarter investment decisions.
About LHDX
Lucira Health, Inc. is medical technology company. The Company is focused on the development and commercialization of transformative and infectious disease test kits. The Company has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and test kit that is powered by two AA batteries and fit in the palm of a hand. Its initial focus is within respiratory diseases, starting with COVID-19 and influenza A and B virus indications. It has developed LUCIRA COVID-19 All-In-One Test Kit (COVID-19 test kit), is a single-use, molecular in vitro diagnostic test that has an analytical sensitivity to detect the SARS-CoV-2 virus. The test is authorized for prescription at-home use.